BeOne Medicines to Present at Upcoming Investor Conferences
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in fireside chats at two upcoming investor conferences:
- Guggenheim Second Annual Healthcare Innovation Conference on Monday, November 10, 2025 at 9:30 am EST; and
- Jefferies Global Healthcare Conference in London on Monday, November 17, 2025 at 4:00 pm GMT/11:00 am EST
Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website.
About BeOne Medicines
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.
To learn more about BeOne, please visit www.beonemedicines.com and follow us on LinkedIn, X, Facebook and Instagram.
Forward-Looking Statements
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including statements regarding BeOne’s plans, commitments, aspirations and goals related to BeOne’s medicines and drug candidates. Actual results may differ materially from those indicated in the forward-looking statements as a result of various important factors which are discussed in the section entitled “Risk Factors” in BeOne’s most recent periodic report filed with the U.S. Securities and Exchange Commission (“SEC”) as well as discussions of potential risks, uncertainties, and other important factors in BeOne’s subsequent filings with the SEC. All information in this press release is as of the date of this press release, and BeOne undertakes no duty to update such information unless required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251028966834/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Merck Partners with Promega to Advance 3-D Cell Drug Discovery Technologies28.10.2025 14:16:00 CET | Press release
Partnership combines Merck’s chemistry and organoid expertise with Promega’s assay technologies Aims to improve researcher access to disease-relevant cell models Strengthens Merck’s leadership in next-generation biology Merck, a leading science and technology company, has entered into a partnership with Promega Corporation, a global life science solutions and service leader based in Madison, Wisconsin in the US, to co-develop novel technologies that advance drug screening and discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251028493228/en/ Merck and Promega will co-develop novel technologies that advance drug discovery. The agreement unites Merck’s strength in organoids and synthetic chemistry with Promega's market leading assay and reporter technologies. Together, the companies aim to develop assays capable of tracking cellular activity in real time using an innovative reporter system within three-dimensional (3D)
Guidewire Signs Definitive Agreement to Acquire ProNavigator28.10.2025 14:00:00 CET | Press release
AI-powered knowledge management platform puts expertise at the fingertips of every insurance professional CONNECTIONS CONFERENCE--Guidewire (NYSE: GWRE) today announced that it has entered into a definitive agreement to acquire ProNav Technologies Ltd. (d/b/a ProNavigator), a knowledge management platform purpose-built for the P&C insurance industry. ProNavigator delivers precise, context-aware best practice information directly within insurance workflows, helping professionals work faster and more effectively. Its platform captures, connects, and surfaces institutional knowledge across claims, underwriting, and distribution. Used by 34 insurance organizations, including 12 shared customers with Guidewire, ProNavigator helps increase productivity, reduce claim cycle times, personalize customer service, and accelerate employee onboarding. Once the acquisition is complete, Guidewire will integrate ProNavigator’s insurance-trained intelligence across its platform, delivering advanced sear
Rimini Street Introduces Agentic AI ERP in Groundbreaking White Paper28.10.2025 14:00:00 CET | Press release
Rimini Street declares ERP Software dead and unveils Agentic AI ERP, a next generation, transformative ERP technology that delivers innovation faster, better and cheaper with more agility, deployed over existing ERP Software with no required, costly ERP upgrades Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, managed services and Agentic AI ERP innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced the publication of its latest thought leadership white paper, The Rise of Agentic AI ERP. This landmark document presents a vision and roadmap for the next-generation technology and tools that will eventually replace today’s ERP Software which has become too big, complex, inflexible and expensive to meet the needs of a fast-changing world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251028696910/en/ Rimini Street In
Gurobi Appoints Dr. Oliver Bastert as Chief Technology Officer28.10.2025 14:00:00 CET | Press release
Dr. Bastert leads Gurobi’s R&D team, advancing innovation in the company’s optimization technology. Gurobi Optimization, LLC, the leader in decision intelligence technology, is pleased to announce the appointment of Dr. Oliver Bastert to the role of Chief Technology Officer, leading the company’s Research and Development team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251028639754/en/ Dr. Oliver Bastert, CTO, Gurobi Optimization "We are thrilled to have Dr. Bastert onboard as our Chief Technology Officer,” said Duke Perrucci, CEO of Gurobi Optimization. “Oliver plays a pivotal role in advancing our solver and driving innovation. As we continue our mission to bring optimization everywhere, his leadership will be instrumental." Dr. Bastert joined the Gurobi team in February and brings over 20 years of experience in B2B software, SaaS, and AI technologies. Prior to joining Gurobi, he served as Vice President of Product Man
Fortegra Insurance UK Limited Achieves NAIC Alien Insurer Registration28.10.2025 14:00:00 CET | Press release
Fortegra Insurance UK Limited, part of the Fortegra Group — a global specialty insurer — has been officially admitted to the National Association of Insurance Commissioners (NAIC) Quarterly Listing of Alien Insurers, formalized in the NAIC’s October Edition 249. The registration creates a differentiated platform that enables Fortegra’s agents and brokers in the United Kingdom to serve their customers who need specialized U.K.-domiciled capacity to address risks that require a U.S. surplus lines solution. “Our alien insurer listing offers UK Managing General Agents (MGAs) a straightforward way to access U.S. surplus lines business. Additionally, our strong presence in the London market fosters natural connections among brokers and agents, as well as the capacity to address complex risks. This combination of strengths sets us apart in the marketplace and allows us to uphold our rigorous underwriting standards while pursuing selective growth with high-quality program partners,” said Richa
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom